Early cancers of the skin: Clinical, histopathological, and molecular characteristics

International Journal of Clinical Oncology

Volumn 10, Issue 6, 2005, Pages 391-397

  Takata, Minoru ^a   Saida, Toshiaki ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CDKN2A; Gene amplification; Gene mutation; Melanoma in situ; p53; Solar keratosis

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; PROTEIN P14; PROTEIN P16INK4A; PROTEIN P53; TELOMERASE REVERSE TRANSCRIPTASE;

ACTINIC KERATOSIS; CANCER DIAGNOSIS; CARCINOGENESIS; DNA DAMAGE; GENE MUTATION; GENOTOXICITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCID MOUSE; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET IRRADIATION;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; EARLY DIAGNOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINOCYTES; MELANOCYTES; MELANOMA; MUTATION; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 29244448273     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-005-0532-7     Document Type: Review

References (44)

1. A Breslow 1970 Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma Ann Surg 172 902 908
2. CM Balch TM Murad SJ Soong 1978 A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods Ann Surg 188 732 742
3. DT Guerry M Synnestvedt DE Elder 1993 Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent J Invest Dermatol 100 342S 345S
4. RJ Friedman DS Rigel AW Kopf 1985 Early detection of malignant melanoma: the role of physician examination and self-examination of the skin CA Cancer J Clin 35 130 151
5. RP Braun HS Rabinovitz M Oliviero 2005 Dermoscopy of pigmented skin lesions J Am Acad Dermatol 52 109 121
6. LJ van 't Veer BM Burgering R Versteeg 1989 N-ras mutations in human cutaneous melanoma from sun-exposed body sites Mol Cell Biol 9 3114 3116
7. H Davies GR Bignell C Cox 2002 Mutations of the BRAF gene in human cancer Nature 417 949 954
8. K Omholt A Platz L Kanter 2003 NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression Clin Cancer Res 9 6483 6488
9. C Cohen A Zavala-Pompa JH Sequeira 2002 Mitogen-activated protein kinase activation is an early event in melanoma progression Clin Cancer Res 8 3728 3733
10. JL Maldonado J Fridlyand H Patel 2003 Determinants of BRAF mutations in primary melanomas J Natl Cancer Inst 95 1878 1890
11. M Takata Y Goto N Ichii 2005 Constitutive activation of the MAPK signaling pathway in acral melanomas J Invest Dermatol 125 318 322
12. BC Bastian M Kashani-Sabet H Hamm 2000 Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin Cancer Res 60 1968 1973
13. BC Bastian AB Olshen PE LeBoit 2003 Classifying melanocytic tumors based on DNA copy number changes Am J Pathol 163 1765 1770
14. Ishihara Y, Saida T, Miyazaki A, et al. (2005) Early acral melanoma in situ diagnosed with a dermoscopic features of the parallel ridge pattern. Am J Dermatopathol (in press)
15. Yamaura M, Takata M, Miyazaki Y, et al. (2005) Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ. Arch Dermatol (in press)
16. BC Bastian 2003 Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer Oncogene 22 3081 3086
17. Y Chudnovsky PA Khavari AE Adams 2005 Melanoma genetics and the development of rational therapeutics J Clin Invest 115 813 824
18. GJ Walker JF Flores JM Glendening 1998 Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets Genes Chromosomes Cancer 22 157 163
19. A Fujimoto R Morita N Hatta 1999 p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma Oncogene 18 2527 2532
20. JA Reed F Loganzo Jr CR Shea 1995 Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression Cancer Res 55 2713 2718
21. D Polsky AZ Young KJ Busam 2001 The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas Cancer Res 61 6008 6011
22. EV Sviderskaya SP Hill TJ Evans-Whipp 2002 p16(Ink4a) in melanocyte senescence and differentiation J Natl Cancer Inst 94 446 454
23. RD Ramirez S D'Atri E Pagani 1999 Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma Neoplasia 1 42 49
24. MY Hsu F Meier M Herlyn 2002 Melanoma development and progression: a conspiracy between tumor and host Differentiation 70 522 536
25. EV Sviderskaya VC Gray-Schopfer SP Hill 2003 p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression J Natl Cancer Inst 95 723 732
26. C Berking R Takemoto K Satyamoorthy 2004 Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B Cancer Res 64 807 811
27. MC Leslie M Bar-Eli 2005 Regulation of gene expression in melanoma: new approaches for treatment J Cell Biochem 94 25 38
28. C Haqq M Nosrati D Sudilovsky 2005 The gene expression signatures of melanoma progression Proc Natl Acad Sci U S A 102 6092 6097
29. R Morita A Fujimoto N Hatta 1998 Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression J Invest Dermatol 111 919 924
30. MR Heaphy Jr AB Ackerman 2000 The nature of solar keratosis: a critical review in historical perspective J Am Acad Dermatol 43 138 150
31. A Ziegler AS Jonason DJ Leffell 1994 Sunburn and p53 in the onset of skin cancer Nature 372 773 776
32. AS Jonason S Kunala GJ Price 1996 Frequent clones of p53-mutated keratinocytes in normal human skin Proc Natl Acad Sci U S A 93 14025 14029
33. ZP Ren F Ponten M Nister 1996 Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis Int J Cancer 69 174 179
34. H Tabata T Nagano AJ Ray 1999 Low frequency of genetic change in p53 immunopositive clones in human epidermis J Invest Dermatol 113 972 976
35. W Zhang E Remenyik D Zelterman 2001 Escaping the stem cell compartment: sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations Proc Natl Acad Sci U S A 98 13948 13953
36. W Zhang AN Hanks K Boucher 2005 UVB-induced apoptosis drives clonal expansion during skin tumor development Carcinogenesis 26 249 257
37. I Rehman M Takata YY Wu 1996 Genetic change in actinic keratoses Oncogene 12 2483 2490
38. ZP Ren A Hedrum F Ponten 1996 Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes Oncogene 12 765 773
39. ZP Ren A Ahmadian F Ponten 1997 Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin Am J Pathol 150 1791 1803
40. DE Brash J Ponten 1998 Skin precancer Cancer Surv 32 69 113
41. DE Brash 1997 Sunlight and the onset of skin cancer Trends Genet 13 410 414
42. M Taguchi S Watanabe K Yashima 1994 Aberrations of the tumor suppressor p53 gene and p53 protein in solar keratosis in human skin J Invest Dermatol 103 500 503
43. R Marks G Rennie TS Selwood 1988 Malignant transformation of solar keratoses to squamous cell carcinoma Lancet 1 795 797
44. L Mortier P Marchetti E Delaporte 2002 Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor Cancer Lett 176 205 214